Skip to main content
eScholarship
Open Access Publications from the University of California

UC San Diego

UC San Diego Electronic Theses and Dissertations bannerUC San Diego

Total synthesis of lysobactin : a natural product antibiotic active against methicillin and vancomycin resistant bacteria

  • Author(s): Guzman-Martinez, Aikomari;
  • et al.
Abstract

Antibiotic resistance has become a significant public health concern. Antibiotics that belong to new structural classes and manifest their biological activity via novel mechanisms are urgently needed. Lysobactin is a cyclic depsipeptide antibiotic produced by a species of Lysobacter (ATCC53042) that was isolated by a group at the Squibb Institute. In a recent evaluation, lysobactin displayed very strong antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA) as well as vancomycin-resistant Enterococci (VRE) with minimum inhibitory concentrations (MICs) ranging from 0.39 to 0.78 [mu]g/mL.12 The MIC values against VRE were more than 50- fold lower than those reported for vancomycin itself. Lysobactin inhibited the incorporation of isotopically labeled N-acetylglucosamine (GlcNAc) into staphylococcal cell wall peptidoglycan with a 50% inhibitory concentration (IC₅₀) 0.78 [mu]g/mL very close to its MIC. Lysobactin was also found to inhibit nascent peptidoglycan formation; however, unlike vancomycin, its activity was not antagonized in the presence of N-acetyl-L-Lys-D-Ala-D- Ala. Thus, if lysobactin achieves its inhibition of the peptidoglycan biosynthetic machinery through binding to the lipid intermediates or nascent peptidoglycan, it does so at a site on these precursors that is not utilized by vancomycin itself. Thus, lysobactin represents a promising agent for the treatment bacterial infections due to resistant pathogens. We describe a convergent synthesis of lysobactin that relies upon a highly efficient macrocyclization reaction to assemble the 28-membered cyclic depsipeptide. This synthesis provides the foundation for further study of the mode of action utilized by lysobactin and its analogues

Main Content
For improved accessibility of PDF content, download the file to your device.
Current View